Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Delayed Quote USD

Zivo Bioscience, Inc. (ZIVOW)

Compare
0.1800
-0.7700
(-81.05%)
At close: April 1 at 4:00:00 PM EDT
Loading Chart for ZIVOW
  • Previous Close 0.9500
  • Open 1.0000
  • Bid 1.2500 x 40000
  • Ask 1.2900 x 40000
  • Day's Range 0.7500 - 1.0000
  • 52 Week Range 0.7500 - 1.0000
  • Volume 1,800
  • Avg. Volume --
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.11
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

www.zivobioscience.com

7

Full Time Employees

--

Fiscal Year Ends

Recent News: ZIVOW

View More

Compare To: ZIVOW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZIVOW

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -759.60%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    157.22k

  • Net Income Avi to Common (ttm)

    -13.38M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.54M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    752.71k

Research Analysis: ZIVOW

View More

Company Insights: ZIVOW

Research Reports: ZIVOW

View More

People Also Watch